close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Evan Pisick

location-icon

Zion, IL

LOCATION OF PRACTICE
Unitypoint Health-meriter
MEDICAL Specialty:

Lung Cancer, Metastatic Respiratory System Cancer, Retroperitoneum Cancer



2520 ELISHA AVENUE, ZION, IL, 60099
2361 PAYSPHERE CIRCLE, CHICAGO, IL, 60674
800-322-9183
NPI Number
1427096700
ABOUT

Evan Pisick, MD, is a Medical Oncologist in Zion, IL. He has 25 years of experience and is board certified in Hematology, frequently treating conditions such as Retroperitoneum Cancer and Lung Cancer. Pisick graduated from Boston University and completed his residency at Mount Sinai Hospital.

Dr. Evan Pisick profile image

Published Articles

Pertuzumab and Trastuzumab in Patients With ERBB2/3-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry Study.- 2026 Apr
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With High Tumor Mutation Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.- 2026 Apr
Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.- 2026 Apr
Olaparib in Patients With Solid Tumors With ATM Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.- 2026 Jan
Immunotherapy in Head and Neck Cancer.- 2025
Current paradigm of EGFR(ins20) in non-small cell lung cancer: A long way forward.- 2025 Sep 12
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.- 2024 Oct
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.- 2024 Jun 5
Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.- 2024 Apr
Novel BRD2::NUTM1 Fusion in NUT Carcinoma With Exceptional Response to Chemotherapy: A Case Report.- 2024 Jan

Clinical Trials

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Black Cohosh for Host Flashes Due to Androgen Deprivation Therapy
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Other Specialists treating Lung Cancer, Metastatic Respiratory System Cancer, Retroperitoneum Cancer in Zion, IL

See All Doctors

Dr. Glynis Vashi

Specialty: Liver Cancer, Retroperitoneum Cancer, Bone Cancer

My Resources
location-icon

Midwestern Region Medical Center

My Resources

Dr. Rakhshanda Neelam

Specialty: Breast Cancer, Anemia, Lung Cancer

My Resources
location-icon

Decatur Memorial Hospital

My Resources

Dr. Karen Smorowski

Specialty: Metastatic Respiratory System Cancer, Bone Cancer, Thyroid Cancer

My Resources
location-icon

Southeastern Regional Medical Center

My Resources

Dr. Ryan Engel

Specialty: Lymphocytopenia, Lung Cancer, Retroperitoneum Cancer

My Resources
location-icon

Javon Bea Hospital-Riverside

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider